To export finished pharmaceutical formulations to Honduras, Indian companies must navigate the registration process overseen by the Agencia de Regulación Sanitaria (ARSA), the country's health regulatory authority. The process involves submitting a comprehensive dossier that adheres to ARSA's guidelines, which are aligned with WHO-GMP standards. This dossier should include administrative documents such as a Free Sale Certificate (FSC) and a WHO-GMP Certificate, both apostilled to confirm authenticity. Technical documents required encompass the Quality and Quantity (Q&Q) formula, Finished Product Specifications, Method of Analysis, Finished Product Monograph, Method Validations, and Certificates of Analysis (CoA) for both the Active Pharmaceutical Ingredient (API) and the finished product. Additionally, stability data must be provided, demonstrating the product's shelf-life under conditions corresponding to climatic Zone IVb (30°C ± 2°C, 75% ± 5% relative humidity).
The dossier should be organized in a format similar to the Common Technical Document (CTD), though not strictly adhering to the ICH-CTD structure. All documents originating from India must be notarized and apostilled to ensure their acceptance by ARSA. Once submitted, the evaluation process for product registration typically takes 210 working days. It's important to note that the Sanitary Registration Number (SRN) issued by ARSA is valid for five years, after which renewal is necessary.
